Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Dec;31(12):1887–1891. doi: 10.1128/aac.31.12.1887

Phenotypic expression and genetic heterogeneity of lincosamide inactivation in Staphylococcus spp.

R Leclercq 1, A Brisson-Noël 1, J Duval 1, P Courvalin 1
PMCID: PMC175821  PMID: 3439797

Abstract

We examined the resistance phenotype and the genetic basis of lincosamide modification in 25 clinical isolates of Staphylococcus spp. inactivating lincomycin and clindamycin. The strains were resistant to high levels of lincomycin but remained susceptible to clindamycin. However, MBCs and inoculum effects showed that the activity of clindamycin was impaired. The distribution in these strains of nucleotide sequences related to linA and linA', the genes encoding lincosamide nucleotidylation in Staphylococcus haemolyticus BM4610 and S. aureus BM4611, respectively, was studied by dot blot hybridization. The genes responsible for lincosamide inactivation in Staphylococcus spp. were found to constitute a family of related sequences which are not species specific.

Full text

PDF
1891

Images in this article

1890Image
on p.1890

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brisson-Noël A., Courvalin P. Nucleotide sequence of gene linA encoding resistance to lincosamides in Staphylococcus haemolyticus. Gene. 1986;43(3):247–253. doi: 10.1016/0378-1119(86)90213-1. [DOI] [PubMed] [Google Scholar]
  2. CHABBERT Y. Antagonisme in vitro entre l'érythromycine et la spiramycine. Ann Inst Pasteur (Paris) 1956 Jun;90(6):787–790. [PubMed] [Google Scholar]
  3. Courvalin P., Ounissi H., Arthur M. Multiplicity of macrolide-lincosamide-streptogramin antibiotic resistance determinants. J Antimicrob Chemother. 1985 Jul;16 (Suppl A):91–100. doi: 10.1093/jac/16.suppl_a.91. [DOI] [PubMed] [Google Scholar]
  4. Devriese L. A. Two new types of resistance to lincomycin in pathogenic staphylococci from animals. Ann Microbiol (Paris) 1980 Nov-Dec;131B(3):261–266. [PubMed] [Google Scholar]
  5. Dhawan V. K., Thadepalli H. Clindamycin: a review of fifteen years of experience. Rev Infect Dis. 1982 Nov-Dec;4(6):1133–1153. doi: 10.1093/clinids/4.6.1133. [DOI] [PubMed] [Google Scholar]
  6. Gots J. S. THE DETECTION OF PENICILLINASE-PRODUCING PROPERTIES OF MICROORGANISMS. Science. 1945 Sep 21;102(2647):309–309. doi: 10.1126/science.102.2647.309. [DOI] [PubMed] [Google Scholar]
  7. Horinouchi S., Weisblum B. Nucleotide sequence and functional map of pE194, a plasmid that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibodies. J Bacteriol. 1982 May;150(2):804–814. doi: 10.1128/jb.150.2.804-814.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hu N., Messing J. The making of strand-specific M13 probes. Gene. 1982 Mar;17(3):271–277. doi: 10.1016/0378-1119(82)90143-3. [DOI] [PubMed] [Google Scholar]
  9. Kloos W. E., Schleifer K. H. Simplified scheme for routine identification of human Staphylococcus species. J Clin Microbiol. 1975 Jan;1(1):82–88. doi: 10.1128/jcm.1.1.82-88.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lampson B. C., Parisi J. T. Nucleotide sequence of the constitutive macrolide-lincosamide-streptogramin B resistance plasmid pNE131 from Staphylococcus epidermidis and homologies with Staphylococcus aureus plasmids pE194 and pSN2. J Bacteriol. 1986 Sep;167(3):888–892. doi: 10.1128/jb.167.3.888-892.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Leclercq R., Carlier C., Duval J., Courvalin P. Plasmid-mediated resistance to lincomycin by inactivation in Staphylococcus haemolyticus. Antimicrob Agents Chemother. 1985 Sep;28(3):421–424. doi: 10.1128/aac.28.3.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Messing J., Vieira J. A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments. Gene. 1982 Oct;19(3):269–276. doi: 10.1016/0378-1119(82)90016-6. [DOI] [PubMed] [Google Scholar]
  13. Monod M., Denoya C., Dubnau D. Sequence and properties of pIM13, a macrolide-lincosamide-streptogramin B resistance plasmid from Bacillus subtilis. J Bacteriol. 1986 Jul;167(1):138–147. doi: 10.1128/jb.167.1.138-147.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Novick R. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology. 1967 Sep;33(1):155–166. doi: 10.1016/0042-6822(67)90105-5. [DOI] [PubMed] [Google Scholar]
  15. Rasmussen J. L., Odelson D. A., Macrina F. L. Complete nucleotide sequence and transcription of ermF, a macrolide-lincosamide-streptogramin B resistance determinant from Bacteroides fragilis. J Bacteriol. 1986 Nov;168(2):523–533. doi: 10.1128/jb.168.2.523-533.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tenover F. C. Studies of antimicrobial resistance genes using DNA probes. Antimicrob Agents Chemother. 1986 May;29(5):721–725. doi: 10.1128/aac.29.5.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Trieu-Cuot P., Courvalin P. Evolution and transfer of aminoglycoside resistance genes under natural conditions. J Antimicrob Chemother. 1986 Oct;18 (Suppl 100):93–102. doi: 10.1093/jac/18.supplement_c.93. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES